Sign In
Buy IGF
$66.81
-0.190 (-0.284%)
At Close: Jul 31, 2026
Bright Spots: Bucking Thematic ETFs' Downtrend
01:29pm, Wednesday, 27'th Nov 2024
Thematic ETFs have had a tough slog – now headed for a third-straight year of losses. Roughly 90 thematic ETFs debuted back in 2021, compared to fewer than 20 this year.
IGF: How To Capitalize On Urbanization
08:30am, Tuesday, 20'th Aug 2024
Infrastructure investment, is crucial for economic growth and stability, essential for cities' functioning and growth. iShares Global Infrastructure ETF invests in large-cap companies across the energ
SAN FRANCISCO and SUZHOU, China , May 20, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commerciali
This Sector Is Crushing the S&P 500 in 2024 (and It's Not Tech)
03:02am, Saturday, 30'th Mar 2024
The industrial sector, particularly industries relating to heavy machinery, is thriving. Industrials balance growth and income.
GRID: Excellent Smart Grid ETF For The Global Electrification Theme
07:03pm, Friday, 28'th Jul 2023
GRID: Excellent Smart Grid ETF For The Global Electrification Theme
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the first patient has been enrolled in a Phase 3 clinical trial in Japan evaluating TEPEZZA for the treatment of a
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the Indications and Usage section of the TEP
Daiwa Health Development Launches New Product to Support Digestive Health
06:47pm, Wednesday, 12'th Apr 2023
GARDENA, Calif.--(BUSINESS WIRE)--Daiwa Health Development, a leading provider of natural health and wellness products, announces the launch of its new product, Daiwa GastroImmune™. Powered by Immun
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced positive and statistically significant topline results from its randomized, double-masked, placebo-controlled Phase 4 c
SAN FRANCISCO--(BUSINESS WIRE)--This year’s Game Developers Conference (GDC), the world’s largest and longest-running event serving professionals dedicated to the art and science of making games,
India Global Forum’s Annual Summit Wraps up on a High Note, Setting the Pace for India’s Determined March on the World Stage
02:15am, Wednesday, 29'th Mar 2023
New Delhi , India The India Global Forum’s (IGF) flagship Annual Summit, around the theme of “Setting the Pace“, concluded successfully with stakeholders across sectors sharing their views on ho
Betrayal At Club Low Wins the Seumas McNally Grand Prize at the 25th Annual Independent Games Festival Awards
10:35pm, Wednesday, 22'nd Mar 2023
SAN FRANCISCO--(BUSINESS WIRE)--Cosmo D Studios’ Betrayal At Club Low won the Seumas McNally Grand Prize for Best Independent Game at the 25th annual Independent Games Festival (IGF) Awards tonight.
2023 Game Developers Conference Opens Today at San Francisco’s Moscone Convention Center
11:00am, Monday, 20'th Mar 2023
SAN FRANCISCO--(BUSINESS WIRE)--The 2023 Game Developers Conference (GDC), the world’s largest event for professionals dedicated to the art and science of making games, begins its 37th edition today
Curi Bio Launches MantaReady™ 3D Skeletal Muscle Tissue Media
09:00am, Tuesday, 14'th Mar 2023
SEATTLE--(BUSINESS WIRE)--Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, today announced the commercial launch of their MantaReady™ Skeletal Muscle Media optimi
3 High-Yield ETFs for Passive Income
06:45am, Friday, 03'rd Mar 2023
Reliable ETFs from Vanguard and BlackRock provide a starting point for income-oriented investors.
